Boston is the apex of today’s biotechnology world. With over 250 companies in Boston, Cambridge, and surrounding suburbs, nearly every pharmaceutical company has a stake in Boston’s biotech network.
Meghan Davis was able to pack a whole lot of research and fun into her four-month co-op in Glasgow, Scotland.
Leah Simmons thought she knew exactly what she wanted, until she didn’t. But she was able to figure out her way through co-ops and research opportunities.
Alexander R. Ivanov’s paper, “Mass-Spectrometry-Based Molecular Characterization of Extracellular Vesicles: Lipidomics and Proteomics” was recognized by C&EN’s publication ‘Supplement” as one of the top ten chromatography and mass spectrometry papers.
Tali Soroker is soaking up as much of Israel as she can, living close to a massive market and the beach. But she spends much of her time on the job at her co-op.
Slava Epstein’s cutting edge research on microbes is highlighted in The New Yorker.
Jonathan Grabowski talks about his ongoing research in the Gulf of Maine in a recent Nature Conservancy video.
A short course by Olga Vitek focused on how to keep up in the field of proteomics when the rapid advancements make it tough to interpret and translate meaningful results.
ICYMI: Reports of the arrival in the U.S. of a new superbug that is resistant to an antibiotic of last resort have set off alarm bells among public health officials. Northeastern professor Kim Lewis explains the new superbug, how worried we should be, and how it might be stopped.
Charlotte Pratt says a highlight of her co-op in Spain is being able to merge her major of linguistics with learning about business, which she says will be helpful in the future.